{"transactions":[{"id":2332850,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":129096,"kind":"person","name":"Pfost Dale R","position":1,"cik":"0001394663","reported_name":"Pfost Dale R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-15T16:10:10.000Z","date":"2021-10-25","kind":"grant","acquired":true,"shares":459353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable over a period of four (4) years with one quarter (1/4) of the options vesting on October 25, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":459353,"derivative":{"exercise_price":10.05,"expiration_date":"2031-10-25","underlying":"American Depositary Shares","underlying_shares":459353},"source":{"system":"sec-edgar","filing":"0001178913-22-001120","document":"zk2227489.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394663/000117891322001120/zk2227489.xml","form_type":"4"}},{"id":2332849,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":129096,"kind":"person","name":"Pfost Dale R","position":1,"cik":"0001394663","reported_name":"Pfost Dale R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2022-03-15T16:10:10.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":700,"price":3.97,"value":2779.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001178913-22-001120","document":"zk2227489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394663/000117891322001120/zk2227489.xml","form_type":"4"}},{"id":2332848,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":129096,"kind":"person","name":"Pfost Dale R","position":1,"cik":"0001394663","reported_name":"Pfost Dale R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"American Depositary Shares","published_at":"2022-03-15T16:10:10.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":1800,"price":3.98,"value":7164.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001178913-22-001120","document":"zk2227489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394663/000117891322001120/zk2227489.xml","form_type":"4"}}]}